YAP1 and non-small cell lung carcinoma: The transcriptional co-activator YAP (YAP1) and its paralog TAZ (WWTR1) are downstream effectors of the Hippo signaling pathway and have well-characterized oncogenic roles in many solid cancers, including NSCLC [84,85].